At what enterprise value was SIMONMED IMAGING acquired in 2021?

You can find the full valuation details of SIMONMED IMAGING on mynth capital. The transaction's Enterprise Value is estimated to be in the range of 500M - 1.5b USD. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 14.8x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of SIMONMED IMAGING when it was acquired by AMERICAN SECURITIES?

The estimated EV/EBITDA multiple for SIMONMED IMAGING is in the range of 5x - 12x. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 14.8x. Join our community for free to access full valuation data and industry trends.

When was SIMONMED IMAGING acquired by AMERICAN SECURITIES?

SIMONMED IMAGING was acquired by AMERICAN SECURITIES in 2021.

What was the EBITDA of SIMONMED IMAGING during the acquisition?

SIMONMED IMAGING's EBITDA is estimated to be in the range of 50M - 100M USD. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the SIMONMED IMAGING acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the SIMONMED IMAGING deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.prnewswire.com/news-releases/simonmed-partners-with-american-securities-301273346.html

← DATABASE

Home Database Healthcare & PharmaSIMONMED IMAGING

04/2021

AMERICAN SECURITIES takes majority stake in SIMONMED IMAGING

UNITED STATES Health Providers / Outpatient Care / Radiology EV 500M - 1.5b USD

Context

SimonMed Imaging has entered into a strategic partnership with American Securities, a leading US private equity firm, as part of a growth investment aimed at supporting the company's next phase of expansion. Following the transaction, American Securities has become a shareholder of SimonMed alongside the company's founder and CEO, Dr. John Simon, who retains a central role in the company's governance and strategic direction. This partnership comes at a time of significant growth in the US outpatient medical imaging market, driven by the increasing shift of diagnostic exams from hospitals to specialized centers offering lower-cost services. American Securities was attracted to SimonMed's unique positioning, which combines the operation of imaging centers with in-house radiologist interpretation, as well as its ability to offer competitive pricing. With this investment, SimonMed aims to accelerate its organic and inorganic growth by strengthening its presence in existing markets and pursuing expansion into new regions across the US. The capital injection will also enable the company to invest further in cutting-edge imaging equipment, artificial intelligence solutions for medical diagnosis, and enhanced patient experience initiatives.

SIMONMED IMAGING, which reported an EBITDA margin of LOGIN in 2020, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Healthcare & Pharma sector (14.8x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

Founded in 2002 by Dr. John Simon and headquartered in Scottsdale, Arizona, SimonMed Imaging is one of the largest independent outpatient medical imaging networks and a leading radiology group in the United States. The company operates over 160 imaging centers across 11 states, performing nearly two million exams annually. Its integrated model combines direct ownership of imaging centers with the employment of specialized radiologists who interpret exams, enabling complete control over the diagnostic value chain. SimonMed offers a comprehensive range of diagnostic imaging services, including MRI, CT scans, ultrasound, 3D mammography, PET/CT, nuclear medicine, DEXA scans, and conventional radiography. The group differentiates itself through its focus on affordable healthcare, utilization of state-of-the-art equipment, and deployment of subspecialized radiologists to enhance diagnostic quality. With over 2,200 employees, including approximately 200 radiologists, SimonMed has established itself as a leading provider of community-based medical imaging services in the United States.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (USD)

Year

Rev

EBITDA

EBIT

2020

2019

Similar deals in Healthcare & Pharma

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
07/2021	OMERS	AMEDES	GERMANY	Health Providers	A consortium led by Goldman Sachs Asset Management and OMERS Infrastructure acquired amedes from Antin Infrastructure Partners. The transaction valued roughly doubling its value since Antin's entry in 2015
05/2021	INFRATIL	PACIFIC RADIOLOGY GROUP	NEW ZEALAND	Health Providers	Infratil acquired a majority stake in Pacific Radiology from its existing doctor shareholders. The remaining equity continues to be held by the group's doctors and management, maintaining a strong clinical alignment
04/2021	ICG / MANAGEMENT & PRIVATE INVESTORS	DOMUSVI	FRANCE	Health Providers	DomusVi completed a major capital reorganization, described as a "jumbo-LBO". This transaction allowed founder Yves Journel to increase his ownership from 30% to 49%, while ICG remains a key controlling partner
03/2021	EQT PARTNERS	CERBA HEALTHCARE	FRANCE	Health Providers	EQT entered into exclusive negotiations to acquire Cerba HealthCare from Partners Group. The transaction values the group at EUR4.5 billion, significantly higher than initial market estimates (EUR3bn)
03/2021	TRITON PARTNERS	BERGMAN CLINICS	NETHERLANDS	Health Providers	Triton completed an investment in Bergman Clinics alongside existing shareholders NPM Capital and the Malenstein family, who both retained minority positions in the business. The transaction followed a competitive sale process mandated to JP Morgan and Axeco Corporate Finance, which attracted interest from TowerBrook Capital Partners, Cinven, Bain Capital, and BC Partners before Triton emerged as the winning bidder
02/2021	SILVER LAKE / NESTLE	IVC EVIDENSIA	UNITED KINGDOM	Health Providers	Silver Lake and Nestle led a EUR3.5 billion capital investment in IVC Evidensia, significantly increasing the group's valuation. The deal allowed EQT VII to partially exit its position, while EQT IX reinvested to remain the majority shareholder
12/2020	MEDIAN KLINIKEN	PRIORY GROUP	UNITED KINGDOM	Health Providers	MEDIAN Kliniken, a Waterland Private Equity portfolio company, agreed to acquire 100% of Priory Group from US-based Acadia Healthcare. Following closing, Waterland intends to combine Priory with MEDIAN to create a leading European rehabilitation and mental health services provider, operating 570 facilities and treating approximately 260,000 patients annually across the UK and Germany
12/2020	RADIOLOGY PARTNERS	MEDNAX RADIOLOGY SOLUTIONS	UNITED STATES	Health Providers	Radiology Partners has completed the acquisition of MEDNAX Radiology Solutions, bringing together two major players in the US radiology market to form a network of over 2,400 radiologists. This strategic move aims to enhance the combined entity's clinical capabilities, expand geographic coverage, and increase access to subspecialty expertise for partner healthcare institutions
12/2020	FRESENIUS	EUGIN GROUP	SPAIN	Health Providers	Fresenius Helios, the hospital and healthcare services division of Fresenius SE & Co. KGaA, acquired Eugin Group from NMC Health, a UAE-based listed healthcare group, through a dual acquisition structure targeting both the global ex-US operations (via Luarmia S.L...
12/2020	ANTIN INFRASTRUCTURE	HIPPOCRATES (LAF - LA FARMACIA)	ITALY	Health Providers	Antin Infrastructure Partners acquired a majority stake (approximately 80%) in Hippocrates Holding. The co-founders reinvested to retain the remaining 20% and maintained their roles as co-CEOs. The original investors (including DVR Capital and Italian family offices such as the Notarbartolo and Marzotto families) sold their shares in this transaction

REFERENCES

Valuation range: EV 500M - 1.5b USD

EBITDA range: 50M - 100M USD

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of SIMONMED IMAGING by AMERICAN SECURITIES are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Target: simonmed imaging

Acquirer: american securities